Category: ACQUISITIONS and MERGERS

Medica Group acquired the company for an initial cash consideration of €16m (£14.5m) from private Irish healthcare group, Centric Health, on a cash-free and debt-free basis, and provides an update on current trading.

By joining the market leaders in virtual care and applied health signals, the combined company becomes the only consumer and healthcare provider partner to span a person’s entire health journey.

The company also announced further enhancement of its ENT portfolio with the recent acquisition of privately-held Ai Biomed Corp., maker of the PTeye™ parathyroid detection system.

In addition, Medtainer, which is a Florida corporation, changed its name to Advanced Container Technologies, Inc., effective October 3, 2020.

The company notes this acquisition further strengthens their position as a leading provider of payer intelligence for the biopharmaceutical and medtech industries.

Exxe Group reported among other elements, the MMeditech acquisition brings immediate revenues to Exxe, a high level of operating profitability, and a backlog of $2.8 million for 2021.

The terms of the transaction were not provided.

The technologies developed by the RCSI Tissue Engineering Research Group have extensive pre-clinical and human data demonstrating their effectiveness in the treatment of both hard and soft tissues.

September 17, 2020 QIAGEN N.V. today announced the acquisition of the remaining 80.1% of diagnostics instruments company NeuMoDx Molecular, Inc. for $248 million in cash. The move rounds out QIAGEN’s portfolio of automated molecular testing solutions based on the proven PCR technology. The transaction was completed after QIAGEN received U.S. regulatory clearance for the full acquisition. In 2018, QIAGEN had purchased a 19.9% stake in NeuMoDx along with the right to acquire the remaining NeuMoDx stake at a price of $234...